Cardinal Health, Inc. (CAH)
NYSE: CAH · IEX Real-Time Price · USD
97.18
-0.25 (-0.26%)
May 15, 2024, 3:15 PM EDT - Market open
Cardinal Health Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Cardinal Health stock have an average target of 107.14, with a low estimate of 85 and a high estimate of 128. The average target predicts an increase of 10.25% from the current stock price of 97.18.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CAH stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 2 | 3 | 4 | 4 | 4 | 4 |
| Hold | 8 | 8 | 8 | 8 | 8 | 7 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 13 | 15 | 15 | 15 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Argus Research | Argus Research | Strong Buy Maintains $120 → $115 | Strong Buy | Maintains | $120 → $115 | +18.34% | May 15, 2024 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $110 → $115 | Hold | Maintains | $110 → $115 | +18.34% | May 3, 2024 |
| Baird | Baird | Buy Maintains $134 → $128 | Buy | Maintains | $134 → $128 | +31.71% | May 3, 2024 |
| Wells Fargo | Wells Fargo | Sell Maintains $96 → $94 | Sell | Maintains | $96 → $94 | -3.27% | Apr 29, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $125 | Buy | Initiates | $125 | +28.63% | Feb 26, 2024 |
Financial Forecast
Revenue This Year
229.22B
from 205.01B
Increased by 11.81%
Revenue Next Year
248.64B
from 229.22B
Increased by 8.47%
EPS This Year
7.37
from 1.00
Increased by 636.93%
EPS Next Year
8.09
from 7.37
Increased by 9.74%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 240.5B | 263.6B | 286.1B | 268.0B | 288.7B |
| Avg | 229.2B | 248.6B | 267.8B | 246.5B | 263.0B |
| Low | 220.2B | 235.8B | 249.5B | 229.0B | 240.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 17.3% | 15.0% | 15.1% | 0.1% | 17.1% |
| Avg | 11.8% | 8.5% | 7.7% | -8.0% | 6.7% |
| Low | 7.4% | 2.9% | 0.3% | -14.5% | -2.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7.72 | 8.85 | 9.93 | 9.70 | 10.55 |
| Avg | 7.37 | 8.09 | 8.80 | 9.03 | 9.68 |
| Low | 7.00 | 7.50 | 7.34 | 8.20 | 8.53 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 672.2% | 20.1% | 22.8% | 10.3% | 16.8% |
| Avg | 636.9% | 9.7% | 8.8% | 2.7% | 7.2% |
| Low | 599.7% | 1.7% | -9.2% | -6.8% | -5.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.